Antithrombotic effects of ticlopidine, acetylsalicylic acid and dipyridamole in vascular shunt model in rats
- 1 March 1980
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 17 (5), 663-671
- https://doi.org/10.1016/0049-3848(80)90369-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Influence of Red Blood Cells on the Effects of Aspirin or Sulphinpyrazone on Platelet Adherence to Damaged Rabbit AortaBritish Journal of Haematology, 1979
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Clinical Pharmacology of a New Antithrombotic Agent, TicloRinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1978
- The AMIS Trial: Can Aspirin Prevent Heart Attacks?Science, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.Circulation, 1975
- Induction of experimental arterial occlusive thrombi in ratsAtherosclerosis, 1973
- EFFECTS OF SALICYLATES ON HUMAN PLATELETSThe Lancet, 1968
- Reduction of clotting in Scribner shunts by long-term anticoagulation.BMJ, 1967